Pro-Dex Inc
$ 40.70
3.93%
04 Dec - close price
- Market Cap 128,445,000 USD
- Current Price $ 40.70
- High / Low $ 40.99 / 39.34
- Stock P/E 11.80
- Book Value 12.73
- EPS 3.32
- Next Earning Report 2026-01-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.11 %
- ROE 0.31 %
- 52 Week High 70.26
- 52 Week Low 23.47
About
Pro-Dex, Inc. (PDEX) specializes in the design and manufacture of advanced powered surgical instruments, serving original equipment manufacturers in the global medical device industry. Based in Irvine, California, the company leverages state-of-the-art engineering and precision manufacturing techniques to deliver innovative solutions that enhance surgical outcomes. With a strong emphasis on research and development, Pro-Dex remains agile and responsive to the changing needs of healthcare professionals, ensuring its competitive advantage in a rapidly evolving market.
Analyst Target Price
$56.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-30 | 2025-09-04 | 2025-05-01 | 2025-01-30 | 2024-10-31 | 2024-09-05 | 2024-05-02 | 2024-02-08 | 2023-11-02 | 2023-09-29 | 2023-05-04 | 2023-02-02 |
| Reported EPS | 1.4 | 0.36 | 0.85 | 0.61 | 0.75 | 0.46 | 0.19 | 0.14 | -0.17 | 0.42 | 0.36 | 0.24 |
| Estimated EPS | 0.5 | 0.47 | 0.47 | 0.38 | 0.29 | 0.35 | 0.35 | 0.35 | 0.32 | 0.33 | 0.26 | 0.29 |
| Surprise | 0.9 | -0.11 | 0.38 | 0.23 | 0.46 | 0.11 | -0.16 | -0.21 | -0.49 | 0.09 | 0.1 | -0.05 |
| Surprise Percentage | 180% | -23.4043% | 80.8511% | 60.5263% | 158.6207% | 31.4286% | -45.7143% | -60% | -153.125% | 27.2727% | 38.4615% | -17.2414% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-01-29 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.59 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PDEX
2025-10-16 20:00:59
Pro-Dex, Inc. issued a clarification regarding its trading symbol. The company specializes in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers primarily for orthopedic, thoracic, and maxillofacial markets. Pro-Dex's product line also includes rotary air motors, though these represent a minimal portion of total revenue.
2025-10-16 20:00:59
Pro-Dex, Inc. announced a clarification related to its trading symbol. The company specializes in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxillofacial markets. Pro-Dex's products, which also include rotary air motors, are utilized in hospitals and medical engineering labs worldwide.
2025-10-16 20:00:00
Pro-Dex, Inc. issued a press release to clarify potential market confusion regarding its trading symbol PDEX. The company, which trades on Nasdaq Capital Market, shares the PDEX symbol with Polkadex, a cryptocurrency that trades on certain crypto exchanges. Pro-Dex, Inc. emphasized that there is no relationship or affiliation between the two entities and urged investors to exercise caution to ensure their research and trades accurately reflect their intent.
2025-10-16 20:00:00
Pro-Dex Inc. issued a market clarification on October 16, 2025, to differentiate its Nasdaq-listed common stock (PDEX) from Polkadex, an unrelated crypto entity using the same symbol. The company emphasized that there is no relationship or affiliation between them and urged investors to carefully verify their research and trades. Pro-Dex specializes in designing and manufacturing medical surgical drivers and shavers.
2025-10-14 10:24:48
Pro-Dex, Inc. (NASDAQ:PDEX) shareholders have experienced a 41% decline in share price over the last three months, despite a 33% gain over three years. While the company's earnings per share grew at a compound annual growth rate of 30% over three years, this outpaced the 10% average annual share price increase, suggesting a cooling market sentiment reflected in its P/E ratio of 9.64. The article also notes a 5.3% shareholder loss for the year compared to a 16% market gain, indicating potential unresolved challenges for Pro-Dex.
